Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease

被引:87
作者
Quinn, J
Montine, T
Morrow, J
Woodward, WR
Kulhanek, D
Eckenstein, F
机构
[1] Portland Vet Affairs Med Ctr, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA
[3] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA
[4] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
[5] Univ Vermont, Med Ctr, Dept Neurol, Burlington, VT USA
关键词
Alzheimer; animal model; cyclooxygenase; nonsteroidal anti-inflammatory drug; oxidative stress; indomethacin; F2-isoprostanes;
D O I
10.1016/S0165-5728(03)00037-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The hypothesis that inflammation and beta amyloid deposition are causally linked in Alzheimer's disease (AD) was tested in a transgenic mouse model. Untreated beta amyloid plaque-bearing Tg2576 mice did not differ from wild type animals in brain levels of most inflammatory mediators. Indomethacin treatment suppressed brain levels of prostaglandins by 90%, but reduced hippocampal beta amyloid by only 20%, with no effect on cortical beta amyloid. The discordant effects on beta amyloid and cyclooxygenase (COX) suggest that these effects of nonsteroidal anti-inflammatory drugs (NSAIDs) are not causally linked. Further evidence against a causal relationship is seen in an unexpected trend to lower levels of beta amyloid after an inflammatory stimulus [lipopolysaccharide (LPS)]. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:32 / 41
页数:10
相关论文
共 46 条
  • [1] Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic mice
    Abbas, N
    Bednar, I
    Mix, E
    Marie, S
    Paterson, D
    Ljungberg, A
    Morris, C
    Winblad, B
    Nordberg, A
    Zhu, J
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2002, 126 (1-2) : 50 - 57
  • [2] Aisen P, 2002, NEUROBIOL AGING, V23, pS429
  • [3] A randomized controlled trial of prednisone in Alzheimer's disease
    Aisen, PS
    Davis, KL
    Berg, JD
    Schafer, K
    Campbell, K
    Thomas, RG
    Weiner, MF
    Farlow, MR
    Sano, M
    Grundman, M
    Thal, LJ
    [J]. NEUROLOGY, 2000, 54 (03) : 588 - 593
  • [4] Cell mediators of inflammation in the Alzheimer disease brain
    Akiyama, H
    Arai, T
    Kondo, H
    Tanno, E
    Haga, C
    Ikeda, K
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 : S47 - S53
  • [5] β-Amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology
    Apelt, J
    Schliebs, R
    [J]. BRAIN RESEARCH, 2001, 894 (01) : 21 - 30
  • [6] Evidence for glial-mediated inflammation in aged APPSW transgenic mice
    Benzing, WC
    Wujek, JR
    Ward, EK
    Shaffer, D
    Ashe, KH
    Younkin, SG
    Brunden, KR
    [J]. NEUROBIOLOGY OF AGING, 1999, 20 (06) : 581 - 589
  • [7] Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
    DiCarlo, G
    Wilcock, D
    Henderson, D
    Gordon, M
    Morgan, D
    [J]. NEUROBIOLOGY OF AGING, 2001, 22 (06) : 1007 - 1012
  • [8] Frautschy SA, 1998, AM J PATHOL, V152, P307
  • [9] Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    Hardy, J
    Selkoe, DJ
    [J]. SCIENCE, 2002, 297 (5580) : 353 - 356
  • [10] Transgenic mice expressing Alzheimer amyloid precursor proteins
    Hsiao, K
    [J]. EXPERIMENTAL GERONTOLOGY, 1998, 33 (7-8) : 883 - 889